Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 5 | 100% |
Develops immune-based biologics for treatment of cancer, autoimmunity, transplantation, and infectious diseases
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 5 | 100% |